A significant reduction in low‐frequency activity (4–12 Hz) was observed in patients with DYT‐SGCE compared to DYT‐THAP1 and idiopathic dystonia, highlighting the potential for personalized aDBS based on genetic factors in dystonia patients. The gene discussed is THAP1; the disease is Dystonia.